BY IDA JORGENSEN
-
Trump reiterates promise of tariffs on pharmaceutical companies
The United States head of state enforced tolls on automobiles on Wednesday evening, advising that pharmaceutical firms will certainly be following.
-
Ellab says goodbye to CEO with immediate effect
A brand-new chief executive officer will certainly take control of in June, and up until after that the CFO is momentarily accountable of the firm.
-
GN expands partnership with Cochlear – focusing on divested Demant area
These are 2 really various locations, and GN can not remain in both of them by itself, claims the Danish hearing team’s R&D supervisor concerning the collaboration.
-
Trump reiterates promise of tariffs on pharmaceutical companies
The US president imposed tariffs on cars on Wednesday night, warning that pharmaceutical companies will be next.
-
Country manager learned about “Danish balance” while family was in Switzerland: “This kind of job comes with certain sacrifices”
Darine Ghanem has been each shocked and disenchanted by Denmark throughout her 4 years as nation supervisor at Roche, residing in Copenhagen. Right here’s what she’s discovered.
-
Relaxed EU sustainability reporting rules stir confusion
A number of profession organizations in the life scientific research sector invite the leisure of EU regulations on sustainability coverage, yet it likewise leaves business in a va…
-
Eli Lilly overtook Novo Nordisk in the US: Next step is global leadership
US-based Eli Lilly desires improve its solid energy and outperform Novo Nordisk in the international weight problems market, states the firm’s exec vice head of state. Expert…
-
These are Novo Nordisk’s opportunities and challenges in the US
” The lesson from the initial months of Trump is that absolutely nothing is unimaginable,” a companion at Boston Consulting Team informs business media Finans.
-
Roche signs multi-year, billion-dollar cancer treatment deal
UK biotech firm might get over 7 billion dkk, counting both in advance repayments and turning points in a brand-new bargain with Roche.
-
Bavarian Nordics launches chikungunya vaccine in the US market
The Danish firm got FDA authorization a month back, and the injection is approximated deserve approximately USD 500m.